Virogen Biotechnology

Executive Summary

Virogen Biotechnology, founded in 1995 and headquartered in San Diego, is a private U.S. company specializing in the production of antigens, antibodies, and contract research services for the diagnostics and infectious disease markets. With a focus on providing biological reagents for research and diagnostic applications, Virogen serves a global client base, leveraging its expertise in reagent development to support both commercial and academic laboratories. The company's long-standing presence in the industry underscores its reliability and technical proficiency, though it operates in a competitive landscape with many established players. As a private entity with no disclosed funding or valuation, Virogen appears to be a stable, bootstrapped operation, generating revenue through product sales and service contracts.

Upcoming Catalysts (preview)

• Q4 2026Launch of Expanded Antigen Panel for Emerging Infectious Diseases65% success
• Q2 2027Partnership with Major Diagnostic Kit Manufacturer50% success
• Q1 2027FDA Emergency Use Authorization for Novel Antibody Reagent40% success